Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic) and chronic weight management (Wegovy)
Not a fixed schedule adjusted as your body responds
One vial per cycle
Regarding safety issues, gastrointestinal side effects, including nausea, vomiting, and diarrhea, seemed to be the most frequent adverse events in the GLP-1RAs treatment group
US$ 27.35
US$ 24.75
US$ 28.97
US$ 25.88
US$ 29.05
US$ 28.49
US$ 20.34
US$ 26.61
